Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset

被引:110
作者
Ferrannini, Ele [1 ]
Mari, Andrea [2 ]
Nofrate, Valentina [2 ]
Sosenko, Jay M. [3 ]
Skyler, Jay S. [3 ]
机构
[1] Univ Pisa, Sch Med, Dept Med, I-56100 Pisa, Italy
[2] CNR, Inst Biomed Engn, Padua, Italy
[3] Univ Miami, Div Endocrinol, Miami, FL USA
基金
美国国家卫生研究院;
关键词
ANTIBODY-POSITIVE RELATIVES; GLUCOSE-TOLERANCE TEST; TRIAL-TYPE; INSULIN-RESISTANCE; PREVENTION TRIAL-TYPE-1; INTERVENTION TRIAL; RISK-FACTOR; PREDICTION; SECRETION; MELLITUS;
D O I
10.2337/db09-1378
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Relatives of type I diabetic patients are at enhanced risk of developing diabetes. We investigated the mode of onset of hyperglycemia and how insulin sensitivity and beta-cell function contribute to the progression to the disease. RESEARCH DESIGN AND METHODS-In 328 islet cell autoantibody-positive, nondiabetic relatives from the observational arms of the Diabetes Prevention Trial-1 Study (median age 11 years [interquartile range 81, sequential OGTTs (2,143 in total) were performed at baseline, every 6 months, and 2.7 years [2.7] later, when 115 subjects became diabetic. P-Cell glucose sensitivity (slope of the insulin-secretion/plasma glucose dose-response function) and insulin sensitivity were obtained by mathematical modeling of the OGTT glucose/C-peptide responses. RESULTS-In progressors, baseline insulin sensitivity, fasting insulin secretion, and total postglucose insulin output were similar to those of nonprogressors, whereas beta-cell glucose sensitivity was impaired (median 48 pmol/min per m(2) per mmol/l [interquartile range 36] vs. 87 pmol/min per m 2 per nimol/l [67]; P < 0.0001) and predicted incident diabetes (P < 0.0001) independently of sex, age, BMI, and clinical risk. In progressors, 2-h glucose levels changed little until 0.78 years before diagnosis, when they started to rise rapidly (similar to 13 mmol . l(-1) . year(-1)); glucose sensitivity began to decline significantly (P < 0.0001) earlier (1.45 years before diagnosis) than the plasma glucose surge. During this anticipation phase, both insulin secretion and insulin sensitivity were essentially stable. CONCLUSIONS-In high-risk relatives, beta-cell glucose sensitivity is impaired and is a strong predictor of diabetes progression. The time trajectories of plasma glucose are frequently biphasic, with a slow linear increase followed by a rapid surge, and are anticipated by a further deterioration of beta-cell glucose sensitivity. Diabetes 59:679-685, 2010
引用
收藏
页码:679 / 685
页数:7
相关论文
共 35 条
[1]   Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk [J].
Bingley, PJ ;
Gale, EAM .
DIABETOLOGIA, 2006, 49 (05) :881-890
[2]   CAN WE REALLY PREDICT IDDM [J].
BINGLEY, PJ ;
BONIFACIO, E ;
GALE, EAM .
DIABETES, 1993, 42 (02) :213-220
[3]   Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT) [J].
Bingley, Polly J. ;
Mahon, Jeffrey L. ;
Gale, Edwin A. M. .
DIABETES CARE, 2008, 31 (01) :146-150
[4]   QUANTIFICATION OF ISLET-CELL ANTIBODIES AND PREDICTION OF INSULIN-DEPENDENT DIABETES [J].
BONIFACIO, E ;
BINGLEY, PJ ;
SHATTOCK, M ;
DEAN, BM ;
DUNGER, D ;
GALE, EAM ;
BOTTAZZO, GF .
LANCET, 1990, 335 (8682) :147-149
[5]   First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes [J].
Chase, HP ;
Cuthbertson, DD ;
Dolan, LM ;
Kaufman, F ;
Krischer, JP ;
Schatz, DA ;
White, NH ;
Wilson, DM ;
Wolfsdorf, J .
JOURNAL OF PEDIATRICS, 2001, 138 (02) :244-249
[6]   Onset of type I diabetes - A dynamical instability [J].
De Blasio, BF ;
Bak, P ;
Pociot, F ;
Karlsen, AE ;
Nerup, J .
DIABETES, 1999, 48 (09) :1677-1685
[7]   Pathogenesis of type 2 diabetes mellitus [J].
DeFronzo, RA .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (04) :787-+
[8]  
Eisenbarth GS, 2004, ADV EXP MED BIOL, V552, P268
[9]   Mode of onset of type 2 diabetes from normal or impaired glucose tolerance [J].
Ferrannini, E ;
Nannipieri, M ;
Williams, K ;
Gonzales, C ;
Haffner, SM ;
Stern, MP .
DIABETES, 2004, 53 (01) :160-165
[10]   Insulin resistance, insulin response, and obesity as indicators of metabolic risk [J].
Ferrannini, Ele ;
Balkau, Beverley ;
Coppack, Simon W. ;
Dekker, Jacqueline M. ;
Mari, Andrea ;
Nolan, John ;
Walker, Mark ;
Natali, Andrea ;
Beck-Nielsen, Henning .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08) :2885-2892